🔔 After the Bell

Index Price Change
S&P 5007,403.05-0.07%
Dow Jones49,686.12+0.32%
Nasdaq26,090.73-0.51%
10Y Treasury4.62%+0.03%
U.S. Dollar98.99-0.33%
Bitcoin$76,881-0.71%

🎯 Session Review

Monday delivered a split decision on Wall Street, much like the courtroom drama unfolding in Oakland, California. The Dow Jones climbed 159 points to close at 49,686, while the S&P 500 barely budged at 7,403 and the Nasdaq slid 134 points, weighed down by rate pressure and rotation.

Treasury yields continued their slow grind higher, with the 10-year touching 4.62 percent. That kind of yield environment tends to put pressure on high-growth tech names, which explains the Nasdaq's underperformance today.

The dollar index dipped to 98.99 and Bitcoin slipped under $77,000, both reflecting a cautious but not panicked tone from investors. Not a dramatic session, but plenty of stories worth unpacking.

📊 Today's Market Movers

▲ Gainers
RAMP +27.29%
BRC +18.9%
BIO +13.85%
D +9.43%
RBLX +9.59%
▼ Losers
AEHR -16.01%
USAR -12.77%
POET -11.02%
AAOI -8.98%
REGN -9.82%
Financial Edge Daily SMS
Your Phone Is Smarter Than Your Inbox

Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.

Text Me the Alerts

🚀 Key Catalysts

The biggest headline grabber was the jury verdict in Oakland clearing Sam Altman, Greg Brockman, and OpenAI of Elon Musk's charity-theft claims. Musk alleged he was cheated out of his charitable contributions when OpenAI shifted toward a for-profit model. The jury disagreed, and the decision removes a cloud of legal uncertainty that has hung over the AI space for months.

On the pharma front, Sanofi (SNY) got a boost after announcing its rare lung disease drug outperformed standard care in a clinical trial, lifting sentiment in the biopharma sector. Meanwhile, Trump's planned expansion of TrumpRx.gov for discounted prescription drugs kept pressure on drug pricing names tracked by tickers like IHE and PJP.

Takeda Pharmaceutical (TAK) had a rough Monday, with a U.S. jury pinning roughly $885 million in damages on the company for delaying a generic constipation drug through an alleged antitrust scheme. Bayer (BAYRY) also moved on news that its Monsanto unit settled PCB cleanup claims from Michigan and Rhode Island for at least $133 million.
Sponsored Content

Trump Just Named His Secret AI Project. It's Called "Golden Dawn."

When a secretive project gets a name, it means we're closer to a breakthrough than most people think. Behind the razor wire of a hidden government lab in Tennessee, 40,000 scientists are finishing work on an AI computer 283 trillion times more powerful than today's data centers — spanning more than 700 miles and built to speed up AI breakthroughs by 36,000%. When Golden Dawn launches, it could instantly leapfrog ChatGPT, Gemini, and Grok — and trigger a $100 trillion reset of the AI markets. Louis Navellier is revealing the one stock at the center of it — down to the ticker.

🎭 Investor Mood

Investor Pulse: Verdict Day Vibes
Today's mood is best described as cautiously optimistic with a side of legal drama. The OpenAI verdict matters because it signals that courts are not eager to unwind the AI industry's pivot toward commercialization, which is good news for the entire ecosystem of companies building on or alongside these platforms.

Alphabet (GOOG, GOOGL) is approaching a $5 trillion market cap, fueled by AI momentum and investor confidence in Google's long-term positioning. That milestone, if crossed, would be a psychological inflection point for the market, reinforcing the idea that AI-driven growth is not slowing down.

At the same time, rising yields are keeping a lid on unbridled enthusiasm. Investors are balancing genuine excitement about innovation against the reality that borrowing costs are still elevated and not falling quickly.

🔍 5 Focus Points for Tomorrow

🤖 Watch Alphabet (GOOG) closely as it eyes the $5 trillion market cap threshold driven by AI momentum
📋 Monitor pharma sector reaction to Trump's planned TrumpRx.gov expansion and its drug pricing implications
📊 Track Takeda (TAK) following the $885 million antitrust damages verdict and any appeal developments
🏛️ Keep an eye on the 10-year Treasury yield at 4.62 percent and whether it pressures Nasdaq growth names further
🏛️ Follow BYD (BYDDF) premium EV strategy as the Denza SUV upgrade signals a shift toward higher-margin vehicles
Sponsored Content

How Mitt Romney Turned $450K Into Up to $100 Million (Tax-Free)

It wasn't stocks. It wasn't real estate. It was a little-known investment vehicle that turned Mitt Romney's $450,000 into as much as $100 million and Peter Thiel used to turn $2,000 into $5 billion within two decades. Now, thanks to a new executive order, regular Americans can access the same type of investment.

💸 Bottom Line

A few trends from today are worth tracking into the rest of the week. BYD (BYDDF, BYDDY) unveiled an upgraded Denza flagship SUV at a price point roughly 5 percent higher than before, a deliberate signal that the EV giant is shifting toward premium positioning and better margins. That strategy deserves attention as legacy automakers watch closely.

Ford (F) is also making moves, signing an agreement with a French electric utility company as it deepens its push into the energy business. The intersection of automakers and energy infrastructure is becoming a real investment theme, not just a talking point.

On the environmental liability front, Volvo Group (VLVCY) settled with California for $197 million over truck emissions violations, a reminder that regulatory risk is still very real for industrial names. Keep an eye on how pharma pricing policy develops around TrumpRx.gov and whether that creates further volatility in healthcare ETFs this week.

📰 Further Reading

Gold Beats U.S. Treasuries And Could Make Your Income Soar
Gold Beats U.S. Treasuries And Could Make Your Income Soar (Ad)

While the world's central banks dump America's bonds for gold, one income expert reveals a quiet $15 fund turning that shift into massive monthly income, up to $1,152 every month.

Watch How to Get Paid from Gold.

$112 Trillion Crisis No One Sees Coming
$112 Trillion Crisis No One Sees Coming (Ad)

Dr. Martin Weiss, who has called major financial events long before others, now warns of a $112 trillion crisis hiding in America's "basement." It's not mortgages again. It's an unseen danger...

Click here to watch the urgent forecast now.

There Are Now Two Kinds of Currencies Operating in America. The Wealthy Use One. Everyone Else Uses the Other
There Are Now Two Kinds of Currencies Operating in America. The Wealthy Use One. Everyone Else Uses the Other (Ad)

One currency gets taxed the moment you earn it and loses value every year. The other compounds, passes between generations, and could be used to buy billion-dollar assets without spending a dollar. Louis Navellier has spent 47 years on the inside of this system. He's come forward to explain it publi...

Watch His Urgent Briefing.